Table 3.

Transfusion characteristics of TRALI Specialized Clinical Center for Outcomes Research subjects with leukemia or lymphoma

CharacteristicTRALI, n = 6Possible TRALI, n = 25TACO, n = 6Controls, n = 30
Total cases, % 7 (6/89) 19 (25/130) 7 (6/83) 18 (30/164) 
Units transfused 1 (1-1) 1 (1-2) 1 (1-2) 2.5 (2-3) 
RBCs, % 50 32 33 73 
Platelets, % 67 72 83 63 
Plasma, % 24 17 
Laboratory results     
 WBC count 1.7 (0.2-2.4) 3.1 (0.2-10.5) 3.6 (0.1-6.9) 1.6 (0.2-4.6) 
 Platelet count 24 (5-33) 25 (12-45) 43 (17-73) 22 (11-35) 
CharacteristicTRALI, n = 6Possible TRALI, n = 25TACO, n = 6Controls, n = 30
Total cases, % 7 (6/89) 19 (25/130) 7 (6/83) 18 (30/164) 
Units transfused 1 (1-1) 1 (1-2) 1 (1-2) 2.5 (2-3) 
RBCs, % 50 32 33 73 
Platelets, % 67 72 83 63 
Plasma, % 24 17 
Laboratory results     
 WBC count 1.7 (0.2-2.4) 3.1 (0.2-10.5) 3.6 (0.1-6.9) 1.6 (0.2-4.6) 
 Platelet count 24 (5-33) 25 (12-45) 43 (17-73) 22 (11-35) 

Subjects are from the TRALI Specialized Clinical Center for Outcomes Research study. Data are reported as median values (interquartile ranges) or numbers (percentages). WBC, white blood cell.

Close Modal

or Create an Account

Close Modal
Close Modal